Biotech Co. Hits Ch. 11, Blames Drug Misfires, Criminal Case
By Jonathan Romeo · February 5, 2024, 6:02 PM EST
DMK Pharmaceuticals has applied for Chapter 11 protection in Delaware, citing recent clinical trial failures and product recalls, as well as the government's allegation that a subsidiary engaged in criminal activities,...
To view the full article, register now.